| Symbol |
Name |
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACTB
|
actin, beta
|
|
ACVR2B
|
activin A receptor, type IIB
|
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADM
|
adrenomedullin
|
|
AFP
|
alpha-fetoprotein
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
APC
|
adenomatous polyposis coli
|
|
AR
|
androgen receptor
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BSG
|
basigin (Ok blood group)
|
|
CA12
|
carbonic anhydrase XII
|
|
CA2
|
carbonic anhydrase II
|
|
CA9
|
carbonic anhydrase IX
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND1
|
cyclin D1
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CD109
|
CD109 molecule
|
|
CD68
|
CD68 molecule
|
|
CDC42SE2
|
CDC42 small effector 2
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CHST3
|
carbohydrate (chondroitin 6) sulfotransferase 3
|
|
CKAP4
|
cytoskeleton-associated protein 4
|
|
CLDN1
|
claudin 1
|
|
CLDN4
|
claudin 4
|
|
CLDN7
|
claudin 7
|
|
COX2
|
|
|
CRABP1
|
cellular retinoic acid binding protein 1
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSD
|
cathepsin D
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
DAP
|
death-associated protein
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DLL1
|
delta-like 1 (Drosophila)
|
|
DUSP6
|
dual specificity phosphatase 6
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
EDN1
|
endothelin 1
|
|
EFNB2
|
ephrin-B2
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
ELAPOR1
|
endosome-lysosome associated apoptosis and autophagy regulator 1
|
|
EPHA3
|
EPH receptor A3
|
|
EPHB2
|
EPH receptor B2
|
|
EPHB4
|
EPH receptor B4
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERRFI1
|
ERBB receptor feedback inhibitor 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
FASN
|
fatty acid synthase
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF3
|
fibroblast growth factor 3
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FKBP4
|
FK506 binding protein 4, 59kDa
|
|
FKBP5
|
FK506 binding protein 5
|
|
FOXC2
|
forkhead box C2
|
|
FOXL2
|
forkhead box L2
|
|
FOXO1
|
forkhead box O1
|
|
FOXR2
|
forkhead box R2
|
|
FST
|
follistatin
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
G6PC
|
glucose-6-phosphatase, catalytic subunit
|
|
GH1
|
growth hormone 1
|
|
GHR
|
growth hormone receptor
|
|
GPX3
|
glutathione peroxidase 3
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HK2
|
hexokinase 2
|
|
HMGN5
|
high mobility group nucleosome binding domain 5
|
|
HOXA10
|
homeobox A10
|
|
HOXA11
|
homeobox A11
|
|
HP
|
haptoglobin
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IL11
|
interleukin 11
|
|
IL6
|
interleukin 6
|
|
INHA
|
inhibin, alpha
|
|
INHBC
|
inhibin, beta C
|
|
INSR
|
insulin receptor
|
|
INTS2
|
integrator complex subunit 2
|
|
IRF1
|
interferon regulatory factor 1
|
|
ITGB4
|
integrin, beta 4
|
|
KCNH6
|
potassium channel, voltage gated eag related subfamily H, member 6
|
|
KLF9
|
Kruppel-like factor 9
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT17
|
keratin 17, type I
|
|
LARP6
|
La ribonucleoprotein domain family, member 6
|
|
LAT
|
linker for activation of T cells
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
|
LIF
|
leukemia inhibitory factor
|
|
LNPEP
|
leucyl/cystinyl aminopeptidase
|
|
LRIG2
|
leucine-rich repeats and immunoglobulin-like domains 2
|
|
LSR
|
lipolysis stimulated lipoprotein receptor
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MSN
|
moesin
|
|
MSTN
|
myostatin
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUC6
|
mucin 6, oligomeric mucus/gel-forming
|
|
NDC80
|
NDC80 kinetochore complex component
|
|
NEU1
|
sialidase 1 (lysosomal sialidase)
|
|
NEURL1
|
neuralized E3 ubiquitin protein ligase 1
|
|
NOTCH1
|
notch 1
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NTSR1
|
neurotensin receptor 1 (high affinity)
|
|
OLFM4
|
olfactomedin 4
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX2
|
paired box 2
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PGF
|
placental growth factor
|
|
PGR
|
progesterone receptor
|
|
PIGR
|
polymeric immunoglobulin receptor
|
|
PIK3R2
|
phosphoinositide-3-kinase, regulatory subunit 2 (beta)
|
|
POTEF
|
POTE ankyrin domain family, member F
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPIB
|
peptidylprolyl isomerase B (cyclophilin B)
|
|
PPME1
|
protein phosphatase methylesterase 1
|
|
PRB1
|
proline-rich protein BstNI subfamily 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
RACGAP1
|
Rac GTPase activating protein 1
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RBP1
|
retinol binding protein 1, cellular
|
|
RCAN1
|
regulator of calcineurin 1
|
|
RHOC
|
ras homolog family member C
|
|
RPE65
|
retinal pigment epithelium-specific protein 65kDa
|
|
RPL36A
|
ribosomal protein L36a
|
|
RRM2
|
ribonucleotide reductase M2
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SHBG
|
sex hormone-binding globulin
|
|
SLC12A9
|
solute carrier family 12, member 9
|
|
SLC16A3
|
solute carrier family 16 (monocarboxylate transporter), member 3
|
|
SLC16A4
|
solute carrier family 16, member 4
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SLIT3
|
slit homolog 3 (Drosophila)
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMUG1
|
single-strand-selective monofunctional uracil-DNA glycosylase 1
|
|
SPRY4
|
sprouty homolog 4 (Drosophila)
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STOML2
|
stomatin (EPB72)-like 2
|
|
SYTL2
|
synaptotagmin-like 2
|
|
TCFL5
|
transcription factor-like 5 (basic helix-loop-helix)
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
THBS2
|
thrombospondin 2
|
|
THEMIS2
|
thymocyte selection associated family member 2
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TSG101
|
tumor susceptibility 101
|
|
UCN
|
urocortin
|
|
UVRAG
|
UV radiation resistance associated
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WNT7A
|
wingless-type MMTV integration site family, member 7A
|
